SB 202190
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-10295-50MG | 50 mg | 89,00 | Add | |
| HY-10295-1ML | 10mM/1mL | 97,00 | Add | |
| HY-10295-100MG | 100 mg | 147,00 | Add | |
| HY-10295-200MG | 200 mg | 265,00 | Add | |
| HY-10295-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 has anti-cancer activity and rescued memory deficits[1][2]. SB202190 induces autophagy[3].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Neurological Disease, Apoptosis,Autophagy,MAPK/ERK Pathway,Stem Cell/Wnt |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.89% |
| Molecular Formula | C20H14FN3O |
| Molecular Weight | 331.34 |
| CAS-Number | 152121-30-7 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
